Trial Profile
A Prospective, Randomized, Single-center, Pilot Study of Envarsus XR to Examine Safety, Medication Adherence, and Patient Reported Outcomes in Adolescent Renal Transplant Recipients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 07 Feb 2023 Planned End Date changed from 15 Jan 2023 to 31 Mar 2023.
- 07 Feb 2023 Planned primary completion date changed from 15 Jan 2022 to 31 Mar 2023.
- 07 Feb 2023 Status changed from recruiting to active, no longer recruiting.